Women's Health and Sexually Transmitted Infections
Sinochips Diagnostics Women’s Health and STI portfolio provides accurate, reliable results–enabling clinicians and labs to elevate patient care in reproductive health.
BD MAX™ Vaginal Panel
Real-Time Polymerase Chain Reaction (RT-PCR)
The BD MAX™ Vaginal Panel performed on the BD MAX System is an automated qualitative in vitro diagnostic test for the direct detection of DNA targets from bacteria associated with bacterial vaginosis (qualitative results reported based on detection and quantitation of targeted organism markers), Candida species associated with vulvovaginal candidiasis, and Trichomonas vaginalis from vaginal swabs in patients who are symptomatic for vaginitis/vaginosis. The test utilizes real-time polymerase chain reaction (PCR) for the amplification of specific DNA targets and utilizes fluorogenic target-specific hybridization probes to detect and differentiate DNA from:
- Bacterial vaginosis markers（Individual markers not reported)
- Lactobacillus spp. (L. crispatus and L. jensenii)
- Gardnerella vaginalis
- Atopobium vaginae
- Bacterial Vaginosis Associated Bacteria-2 (BVAB-2)
- Megasphaera-1
- Candida (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis)
- Candida glabrata
- Candida krusei
- Trichomonas vaginalis
BD MAX™ CT/GC/TV Panel
Real-Time Polymerase Chain Reaction (RT-PCR)
The BD MAX™ CT/GC/TV assay, as performed using the BD MAX System, incorporates automated DNA extraction and real-time polymerase chain reaction (PCR) for the direct, qualitative detection of DNA from Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC) and/or Trichomonas vaginalis (TV). The assay may be used for detection of CT and/or GC DNA in male urine specimens, and the detection of CT, GC and/or TV DNA in female urine specimens, clinician-collected female endocervical swab specimens and patient-collected vaginal swab specimens (in a clinical setting). The assay is indicated for use to aid in the diagnosis of chlamydial urogenital disease, gonococcal urogenital disease and/or trichomoniasis in asymptomatic and symptomatic individuals.
Service Highlights
- FDA-cleared IVD assays
- Results available 3 days after sample receipt at Sinochips Diagnostics Laboratory
- Results directly to ordering HCP using automated LIMS
HSV-1, HSV-2, VZV, CMV Panel
Real-Time Polymerase Chain Reaction (RT-PCR)
The HSV-1, HSV-2, VZV, CMV assay performed on the BD MAX™ System is an automated qualitative in vitro diagnostic test for the direct detection of DNA targets from herpes simplex virus 1 (HSV-1), herpes simplex virus 2 (HSV-2), varicella-zoster virus (VZV), and cytomegalovirus (CMV). The test utilizes real-time polymerase chain reaction (PCR) for the amplification of specific DNA targets and utilizes fluorogenic target-specific hybridization probes to detect and differentiate DNA from:
- • Herpes simplex virus 1 (US4/gG gene)
- • Herpes simplex virus 2 (US6/gD gene)
- • Varicella-zoster virus (ORF71 gene)
- • Cytomegalovirus (DNA polymerase gene)
- • Sample Processing Control (SPC) (Drosophila DNA)
This assay is intended to aid in the diagnosis of individuals with a clinical presentation consistent with HSV-1, HSV-2, VZV, and/or CMV.
Service Highlights
- Results available 3 days after sample receipt at Sinochips Diagnostics Laboratory
- Results directly to ordering HCP using automated LIMS
Partnering with Sinochips Diagnostics Is Easy
Partnering with Sinochips Diagnostics Is Easy
1. Contact us
Contact Sinochips Diagnostics (877) 746-6244. Within 1 business day an account will be created, and you will receive access to our result portal.
2. Receive sample collection kits
Within 1-2 days the healthcare provider (HCP) will receive the sample collection kit for the test.
3. Send samples to us
After the test is ordered by the HCP and patient sample is collected, the HCP will put the sample, and the test order/requisition form in the provided bag and deliver to Sinochips Diagnostics.
4. Receive results
The HCP will receive the results through our result portal within 72 hours.
